TREATMENT OPTIONS FOR PATIENTS WITH STAGE-D1 (T0-3,N1-2,M0) ADENOCARCINOMA OF PROSTATE

被引：68
|
作者：
ZINCKE, H [1 ]
UTZ, DC [1 ]
THULE, PM [1 ]
TAYLOR, WF [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,MED RES STAT SECT,ROCHESTER,MN 55905
来源：
UROLOGY | 1987年 / 30卷 / 04期
关键词：
D O I：
10.1016/0090-4295(87)90290-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：307 / 315
页数：9
相关论文
共 50 条
  • [31] Ukrain therapy of stage T1N0M0 bladder cancer patients
    Uglianitsa, KN
    Nechiporenko, NA
    Nefyodov, LI
    Brzosko, WJ
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1998, 24 (5-6) : 227 - 230
  • [32] THE ROLE OF ADJUVANT THERAPY AFTER RESECTION OF T1 N1 M0 AND T2 N1 M0 NON-SMALL CELL LUNG-CANCER
    FERGUSON, MK
    LITTLE, AG
    GOLOMB, HM
    HOFFMAN, PC
    DEMEESTER, TR
    BEVERIDGE, R
    SKINNER, DB
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 91 (03): : 344 - 349
  • [33] Effect of laparoscopic pelvic lymph node dissection on the natural history of D1 (T1-3, N1-3, M0) prostate cancer
    Cadeddu, JA
    Elashry, OM
    Snyder, O
    Schulam, P
    Moore, RG
    Loughlin, KR
    Winfield, HN
    Clayman, RV
    Kavoussi, LR
    UROLOGY, 1997, 50 (03) : 391 - 394
  • [34] THE ROLE OF LYMPHATIC INVASION IN THE MANAGEMENT OF PATIENTS WITH T1N0M0 PULMONARY ADENOCARCINOMA
    Baisi, Alessandro
    Raveglia, Federico
    Rizzi, Alessandro
    Cioffi, Ugo
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (04): : 1772 - 1772
  • [35] Prognostic assessment of PTK activity in T1-T2, N0-N1, M0 breast cancer: a multicentric retrospective study
    Rostaing-Puissant, B
    Chambaz, EM
    Romain, S
    Spyratos, F
    Daver, A
    Jourdan, ML
    Descotes, F
    Colonna, M
    Martin, PM
    Bolla, M
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 74 (02) : 135 - 141
  • [36] Adjuvant Treatment is Superior to Salvage Therapy for Pathological T2-3N0M0 or T1-4N1M0/T4N0M0 Esophageal Cancer after Radical Surgery
    Ni, W.
    Yang, J.
    Xiao, Z.
    Wang, X.
    Zhou, Z.
    Zhang, H.
    Chen, D.
    Feng, Q.
    Liang, J.
    Lv, J.
    Wang, X.
    Hui, Z.
    Zhang, T.
    Bi, N.
    Deng, L.
    Wang, W.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E175 - E176
  • [37] Prognostic Assessment Of PTK Activity in T1-T2, N0-N1, M0 Breast Cancer: A Multicentric Retrospective Study
    Béatrice Rostaing-Puissant
    Edmond M. Chambaz
    Sylvie Romain
    Frédérique Spyratos
    Alain Daver
    Marie Lise Jourdan
    Françoise descotes
    Marc Colonna
    Pierre M. Martin
    Michel Bolla
    Breast Cancer Research and Treatment, 2002, 74 : 135 - 141
  • [38] TREATMENT OF EARLY CANCER OF THE BREAST (T1N0M0 AND T2N0M0) ON THE BASIS OF HISTOLOGIC CHARACTERISTICS
    NEALON, TF
    NKONGHO, A
    GROSSI, CE
    WARD, R
    NEALON, C
    GILLOOLEY, JF
    SURGERY, 1981, 89 (03) : 279 - 289
  • [39] Microvascular density in T1-T4, N0, M0 colorectal carcinomas and prognosis
    Uribarrena, A. R.
    Ortego, J.
    Fuentes, J.
    Raventos, N.
    Parra, P.
    Uribarrena, E. R.
    HISTOPATHOLOGY, 2008, 53 : 168 - 168
  • [40] A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer
    Stephens, RJ
    Girling, DJ
    Hopwood, P
    Thatcher, N
    LUNG CANCER, 2005, 49 (03) : 395 - 400
12345